Profile data is unavailable for this security.
About the company
Protagenic Therapeutics, Inc. is a biopharmaceutical company specializing in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide (TCAP), an endogenous brain signaling peptide that can dampen overactive stress responses. Its lead compound is a 41-amino-acid synthetic peptide, which focuses on treating various neuro-psychiatric conditions, including depression, anxiety, and post-traumatic stress disorder (PTSD). It operates with a novel mechanism, mirroring the active part of the natural brain hormone TCAP, thereby reducing circulating cortisol levels. In addition, it has a portfolio of earlier stage neuropeptides targeting the TCAP pathway that are in preclinical evaluation. The initial dosage form is intended as a subcutaneous injection but is also amenable to other routes of administration including sublingually or intra-nasally.
- Revenue in USD (TTM)0.00
- Net income in USD-5.00m
- Incorporated1994
- Employees--
- LocationProtagenic Therapeutics Inc149 FIFTH AVENUE, SUITE 500NEW YORK 10010United StatesUSA
- Phone+1 (212) 994-8200
- Fax+1 (302) 636-5454
- Websitehttps://protagenic.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Healthy Extracts Inc | 2.49m | -2.47m | 5.93m | -- | -- | 6.19 | -- | 2.38 | -0.8588 | -0.8588 | 0.8611 | 0.3231 | 0.918 | 0.4921 | 36.50 | -- | -91.32 | -53.78 | -174.02 | -146.65 | 65.90 | 45.68 | -99.48 | -87.53 | 0.1636 | -9.72 | 0.5245 | -- | 10.41 | 105.93 | -151.54 | -- | -- | -- |
Hoth Therapeutics Inc | 0.00 | -7.85m | 5.94m | 2.00 | -- | 0.5993 | -- | -- | -2.44 | -2.44 | 0.00 | 2.03 | 0.00 | -- | -- | 0.00 | -96.38 | -157.07 | -110.40 | -177.32 | -- | -- | -- | -- | -- | -50.23 | 0.00 | -- | -- | -- | 31.01 | -- | -- | -- |
Creative Medical Technology Holdings Inc | 9.00k | -5.29m | 6.02m | 4.00 | -- | 0.5896 | -- | 669.27 | -3.76 | -3.76 | 0.0064 | 7.53 | 0.0006 | 0.4291 | -- | 2,250.00 | -35.36 | -110.00 | -40.34 | -- | 60.00 | 65.82 | -58,739.67 | -7,961.14 | 27.64 | -- | 0.00 | -- | -89.84 | -40.86 | 47.88 | -- | -- | -- |
Kintara Therapeutics Inc | 0.00 | -10.77m | 6.06m | 2.00 | -- | -- | -- | -- | -5.98 | -5.98 | 0.00 | -0.0157 | 0.00 | -- | -- | 0.00 | -179.36 | -220.94 | -316.27 | -329.97 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 40.24 | -- | 78.93 | -- |
Ainos Inc | 122.11k | -13.77m | 6.07m | 46.00 | -- | 0.1952 | -- | 49.74 | -3.32 | -3.32 | 0.0298 | 5.23 | 0.0035 | 0.9854 | 1.21 | 2,654.57 | -39.94 | -36.36 | -42.28 | -58.33 | -207.80 | 36.82 | -11,277.18 | -813.63 | 1.72 | -91.59 | 0.1961 | -- | -96.53 | 9.46 | 1.69 | -- | 66.44 | -- |
Bon Natural Life Ltd | 29.52m | 4.60m | 6.08m | 96.00 | 0.8741 | 0.1443 | 1.10 | 0.206 | 4.99 | 4.99 | 32.10 | 30.23 | 0.7045 | 15.27 | 5.19 | 307,524.60 | 10.86 | 14.04 | 13.69 | 20.68 | 29.94 | 30.00 | 15.42 | 17.62 | 2.41 | 30.54 | 0.0955 | 0.00 | -1.29 | 22.32 | -26.32 | 83.09 | -6.70 | -- |
Protagenic Therapeutics Inc | 0.00 | -5.00m | 6.11m | -- | -- | 1.66 | -- | -- | -1.15 | -1.15 | 0.00 | 0.8271 | 0.00 | -- | -- | -- | -80.91 | -74.49 | -94.48 | -92.56 | -- | -- | -- | -- | -- | -9.56 | 0.00 | -- | -- | -- | -40.64 | -- | -- | -- |
Titan Pharmaceuticals Inc | 185.00k | -5.57m | 6.13m | 4.00 | -- | 0.789 | -- | 33.13 | -7.40 | -7.40 | 0.246 | 8.50 | 0.0305 | -- | 4.51 | 46,250.00 | -91.72 | -96.80 | -138.02 | -156.65 | -- | -- | -3,010.27 | -406.26 | 5.55 | -- | 0.07 | -- | -66.97 | -51.16 | 45.43 | -- | -65.61 | -- |
Theralink Technologies Inc | 635.46k | -13.50m | 6.15m | 16.00 | -- | -- | -- | 9.68 | -0.0027 | -0.0027 | 0.00006 | -0.0093 | 0.2525 | -- | 13.51 | 39,716.25 | -536.39 | -- | -- | -- | 73.50 | -- | -2,124.10 | -- | -- | -1.35 | -- | -- | 6.85 | -- | -138.38 | -- | -- | -- |
Kineta Inc | 5.44m | -14.10m | 6.19m | 11.00 | -- | 2.03 | -- | 1.14 | -1.43 | -1.43 | 0.5297 | 0.278 | 0.3927 | -- | -- | 494,727.30 | -101.57 | -66.16 | -318.39 | -86.61 | -- | -- | -258.65 | -854.74 | -- | -1,310.25 | 0.2011 | -- | 178.65 | 13.89 | 77.76 | -- | -- | -- |
Enzon Pharmaceuticals Inc | 0.00 | 98.00k | 6.19m | 0.00 | 63.22 | 1.77 | -- | -- | 0.0013 | 0.0013 | 0.00 | 0.6197 | 0.00 | -- | -- | -- | 2.88 | -0.8654 | 2.99 | -0.8851 | -- | -- | -- | -159.43 | -- | -- | 0.00 | -- | -100.00 | -- | 106.71 | -55.86 | -- | -- |
Lixte Biotechnology Holdings Inc | 0.00 | -5.09m | 6.21m | 3.00 | -- | 12.55 | -- | -- | -2.77 | -2.77 | 0.00 | 1.78 | 0.00 | -- | -- | 0.00 | -103.09 | -104.18 | -111.07 | -111.05 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 19.41 | -- | -- | -- |
Processa Pharmaceuticals Inc | 0.00 | -11.12m | 6.23m | 13.00 | -- | 0.5619 | -- | -- | -8.72 | -8.72 | 0.00 | 3.88 | 0.00 | -- | -- | 0.00 | -154.40 | -84.35 | -175.45 | -90.03 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 59.45 | -- | -34.05 | -- |
Integrated BioPharma, Inc. | 50.52m | -385.00k | 6.32m | 141.00 | -- | 0.3405 | -- | 0.1251 | -0.0128 | -0.0128 | 1.68 | 0.6168 | 1.95 | 4.21 | 12.26 | 358,269.50 | -1.49 | 15.51 | -1.89 | 27.94 | 6.62 | 12.09 | -0.7621 | 6.44 | 0.8428 | -22.53 | 0.0015 | -- | -9.91 | 3.00 | -101.35 | -- | -14.03 | -- |
Stemtech Corp | 4.64m | -4.08m | 6.32m | 45.00 | -- | -- | -- | 1.36 | -0.0624 | -0.0624 | 0.0619 | -0.0092 | 1.09 | 8.35 | 65.16 | 103,098.40 | -96.70 | -- | -- | -- | 76.09 | -- | -88.58 | -- | 0.1045 | -1.81 | 2.27 | -- | -- | -- | -- | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 31 Dec 2023 | 32.00k | 0.72% |
Geode Capital Management LLCas of 31 Dec 2023 | 25.20k | 0.57% |
FNY Capital Management LPas of 31 Mar 2024 | 18.75k | 0.42% |
SSgA Funds Management, Inc.as of 31 Dec 2023 | 13.81k | 0.31% |
G1 Execution Services LLCas of 31 Dec 2023 | 13.20k | 0.30% |
Tower Research Capital LLCas of 31 Dec 2023 | 9.03k | 0.20% |
Vanguard Global Advisers LLCas of 31 Dec 2023 | 1.17k | 0.03% |
Wells Fargo Bank, NA (Private Banking)as of 31 Dec 2023 | 26.00 | 0.00% |
CWM LLCas of 31 Mar 2024 | 1.00 | 0.00% |
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2023 | 1.00 | 0.00% |